$2.37
+0.29 (+13.94%)
Open$2.20
Previous Close$2.08
Day High$2.48
Day Low$2.20
52W High$6.20
52W Low$1.67
Volume—
Avg Volume8.4K
Market Cap5.37M
P/E Ratio—
EPS$-2.06
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,631.2% upside
Current
$2.37
$2.37
Target
$41.03
$41.03
$36.60
$41.03 avg
$68.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.7K | 56.1K | 1.35M |
| Net Income | -5,536,227 | -41,660,571 | -84,207 |
| Profit Margin | -83,520.0% | -79,344.0% | -6.2% |
| EBITDA | -5,592,021 | -44,418,227 | -111,401 |
| Free Cash Flow | — | — | -113,905 |
| Rev Growth | -88.0% | -88.0% | +20.4% |
| Debt/Equity | — | — | 1.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |